QSAR models to predict mutagenicity of acrylates, methacrylates and α,β-unsaturated carbonyl compounds

Dental Materials

Volumn 26, Issue 5, 2010, Pages 397-415

  Pérez Garrido, Alfonso ^a   Helguera, Aliuska Morales ^b,c   Rodríguez, Francisco Girón ^a   Cordeiro, M Natália D S ^c  

^a CATHOLIC UNIVERSITY OF MURCIA   (Spain)

^b CENTRAL UNIVERSITY OF LAS VILLAS   (Cuba)

^c Campus Universitário de Santiago   (Portugal)

Author keywords

, Unsaturated carbonyl compounds; Dental restorative monomers; Mutagenicity; QSAR

Indexed keywords

AMES TEST; CARBONYL MOIETY; DATA SETS; DESCRIPTORS; GENE MUTATIONS; HUMAN HEALTH RISKS; INDIVIDUAL MODELS; LINEAR DISCRIMINANT ANALYSIS; MAMMALIAN CELLS; MOLECULAR FEATURE; MUTAGENIC EFFECT; MUTAGENICITY; QSAR MODEL; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS; THREE MODELS; UNSATURATED CARBONYL COMPOUNDS;

BIOINFORMATICS; DISCRIMINANT ANALYSIS; FORECASTING; HEALTH RISKS; MAMMALS; MOLECULAR GRAPHICS; MONOMERS; SALTS; SULFUR COMPOUNDS; UNSATURATED COMPOUNDS;

CARBONYLATION;

ACRYLIC ACID DERIVATIVE; ALDEHYDE; KETONE; METHACRYLIC ACID DERIVATIVE; MUTAGENIC AGENT; ORGANIC COMPOUND;

ARTICLE; BIOLOGY; CHEMICAL STRUCTURE; CHEMISTRY; CLUSTER ANALYSIS; COMPUTER PROGRAM; DISCRIMINANT ANALYSIS; EXPERT SYSTEM; HUMAN; MUTAGEN TESTING; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ACRYLATES; ALDEHYDES; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; DISCRIMINANT ANALYSIS; EXPERT SYSTEMS; HUMANS; KETONES; METHACRYLATES; MODELS, MOLECULAR; MUTAGENICITY TESTS; MUTAGENS; ORGANIC CHEMICALS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SOFTWARE;

EID: 77949659248     PISSN: 01095641     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dental.2009.11.158     Document Type: Article

References (93)

1. Asmussen E. Factors affecting the quantity of remaining double bonds in restorative resin polymers. Scand J Dent Res 90 (1982) 490-496
2. Imazato S., McCabe J.F., Tarumi H., Ehara A., and Ebisu S. Degree of conversion of composites measured by DTA and FTIR. Dent Mater 17 (2001) 178-183
3. Hume W.R., and Gerzina T.M. Bioavailability of components of resin-based materials which are applied to teeth. Crit Rev Oral Biol Med 7 (1996) 172-179
4. Schweikl H., Schmalz G., and Rackebrandt K. The mutagenic activity of unpolymerized resin monomers in Salmonella typhimurium and v79 cells. Mutat Res 415 (1998) 119-130
5. Schweikl H., and Schmalz G. Triethylene glycol dimethacrylate induces large deletions in the hprt gene of v79 cells. Mutat Res 438 (1999) 71-78
6. EPA Chemical categories report. Available from: http://www.epa.gov/opptintr/newchems/pubs/chemcat.htm. 2006.
7. (EEC) EEC European council directive 1967/548/eec. 1967.
8. Chung F.L., Roy K.R., and Hecht S.S. A study of reactions of α,β-unsaturated carbonyl compounds with deoxyguanosine. J Org Chem 53 (1988) 14-17
9. Dittberner U., Schmetzer B., GoÉlzer P., Eisenbrand G., and Zankl H. Genotoxic effects of 2-trans-hexenal in human buccal mucosa cells in vivo. Mutat Res 390 (1997) 161-165
10. Glaab V., Collins A.R., Eisenbrand G., and Janzowski C. DNA damaging potential and glutathione depletion of 2-cyclohexene-1-one in mammalian cells, compared to food relevant 2-alkenals. Mutat Res 497 (2001) 185-197
11. 2-(1,3-propano)-2'-deoxyguanosine adducts in mammalian cells. Chem Res Toxicol 9 (1996) 1207-1213
12. Ichihashi K., Osawa T., Toyokuni S., and Uchida K. Endogenous formation of protein adducts with carcinogenic aldehydes: implications for oxidative stress. J Biol Chem 276 (2001) 23903-23913
13. Kautiainen A. Determination of hemoglobin adducts from aldehydes formed during lipid peroxidation in vitro. Chem Biol Interact 83 (1992) 55-63
14. Koleva K.Y., Madden J.C., and Cronin M.T.D. Formation of categories from structure-activity relationships to allow read-across for risk assessment: Toxicity of α,β-unsaturated carbonyl compounds. Chem Res Toxicol 21 (2008) 2300-2312
15. Hansch C., and Leo A. Substituent constants for correlation analysis in chemistry and biology (1979), John Wiley & Sons, New York
16. OECD The Report from the Expert Group on (Quantitative) structure activity relationship ([Q]SARs) on the principles for the validation of (Q)SARs, 49, OECD Series on Testing and Assessment. Paris: OECD, 2004.
17. Yourtee D., Holder A.J., Smith R., Morrill J.A., Kostoryz E., Brockmann W., et al. Quantum mechanical quantitative structure-activity relationships to avoid mutagenicity in dental monomers. J Biomater Sci Polymer Edn 12 (2001) 89-105
18. Holder A.J., and Ye L. Quantum mechanical quantitative structure-activity relationships to avoid mutagenicity. Dent Mater 25 (2009) 20-25
19. Helguera A.M., González M.P., and Rieumont J.B. Tops-mode approach to predict mutagenicity in dental monomers. Polymer 45 (2004) 2045-2050
20. González M.P., Teran MCT, Fall Y., Dias L.C., and Helguera A.M. A topological sub-structural approach to the mutagenic activity in dental monomers. 3. Heterogeneous set of compounds. Bioorg Med Chem 46 (2005) 2783-2790
21. Benigni R., Passerini L., Gallo G., Giorgi F., and Cotta-Ramusino M. QSAR models for discriminating between mutagenic and nonmutagenic aromatic and heteroaromatic amines. Environ Mol Mutagen 32 (1998) 75-83
22. Benigni R., Conti L., Crebelli R., Rodomonte A., and Vari M.R. Simple and α,β-unsaturated aldehydes: correct prediction of genotoxicity activity through structure-activity relationship models. Environ Mol Mutagen 46 (2005) 000-010
23. Benigni R., Passerini L., and Rodomonte A. Structure-activity relationships for the mutagenicity and carcinogenicity of simple and α,β-unsaturated aldehydes. Environ Mol Mutagen 42 (2003) 136-143
24. Yang C., Hasselgren C.H., Boyer S., Arvidson K., Aveston S., Dierkes P., et al. Understanding genetic toxicity through data mining: The process of building knowledge by integrating multiple genetic toxicity databases. Toxicol Mech Meth 18 (2008) 277-295
25. Zhu H., Tropsha A., Fourches D., Varnek A., Papa E., Gramatica P., et al. Combinatorial QSAR modeling of chemical toxicants tested against Tetrahymena pyriformis. J Chem Inf Model 48 (2008) 766-784
26. O'Brien S.E., and de Groot M.J. Greater then the sum of its parts: combining models for useful admet prediction. J Med Chem 48 (2005) 1287-1291
27. Mortelmans K., and Zeiger E. The ames Salmonella/microsome mutagenicity assay. Mutat Res 455 (2000) 29-60
28. Moore MM, DeMarini DM, DeSerres FJ, Tindall KR, editors. Banbury Report 28: Mammalian Cell Mutagenesis. New York: Cold Spring Harbor Laboratory, 1987.
29. Todeschini R, Consonni V, Pavan M. Dragon software version 5.4; 2002.
30. Kovatcheva A., Golbraikh A., Oloff S., Xiao Y.D., Zheng W.F., Wolschann P., et al. Combinatorial QSAR of ambergris fragrance compounds. J Chem Inf Comput Sci 44 (2004) 582-595
31. Duchowicz P.R., González M.P., Helguera A.M., Cordeiro M., and Castro E.A. Application of the replacement method as novel variable selection in QSPR. 2. Soil sorption coefficients. Chemometr Intell Lab Syst 88 (2007) 197-203
32. Pérez-Garrido A., Helguera A.M., Cordeiro MNDS, Abellán A., and Escudero A.G. Convenient QSAR model for predicting the complexation of structurally diverse compounds with β-cyclodextrins. Bioorg Med Chem 17 (2009) 896-904
33. 3. Bioorg Med Chem Lett 15 (2005) 5165-5169
34. González M.P., Terán C., Teijeira M., and Helguera A.M. Radial distribution function descriptors: an alternative for predicting a2a adenosine receptors agonists. Eur J Med Chem 41 (2006) 56-62
35. Lapinsh M., Prusis P., Mutule I., Mutulis F., and Wikberg J.E.S. QSAR and proteo-chemometric analysis of the interaction of a series of organic compounds with melanocortin receptor subtypes. J Med Chem 46 (2003) 2572-2579
36. Hemmateenejad B., Akhond M., Miri R., and Shamsipur M. Genetic algorithm applied to the selection of factors in principal component-artificial neural networks: application to QSAR study of calcium channel antagonist activity of 1,4-dihydropyridines (nifedipine analogous). J Chem Inf Comput Sci 43 (2003) 1328-1334
37. Carotti A., Altomare C., Savini L., Chiasserini L., Pellerano C., Mascia M.P., et al. High affinity central benzodiazepine receptor ligands. Part 3. Insights into the pharmacophore and pattern recognition study of intrinsic activities of pyrazolo[4,3-c]quinolin-3-ones. Bioorg Med Chem 11 (2003) 5259-5272
38. Wang X.H., Tang Y., Xie Q., and Qiu Z.B. QSAR study of 4-phenylpiperidine derivatives as μ opioid agonists by neural network method. Eur J Med Chem 41 (2006) 226-232
39. Zheng F., Bayram E., Sumithran S.P., Ayers J.T., Zhan C.G., Schmitt J.D., et al. QSAR modeling of mono- and bis-quaternary ammonium salts that act as antagonists at neuronal nicotinic acetylcholine receptors mediating dopamine release. Bioorg Med Chem 14 (2006) 3017-3037
40. Liu H.X., and Gramatica P. QSAR study of selective ligands for the thyroid hormone receptor beta. Bioorg Med Chem 15 (2007) 5251-5261
41. Kline T., Andersen N.H., Harwood E.A., Bowman J., Malanda A., Endsley S., et al. Potent, novel in vitro inhibitors of the Pseudomonas aeruginosa deacetylase lpxc. J Med Chem 45 (2002) 3112-3129
42. McElroy N.R., and Jurs P.C. QSAR and classification of murine and human soluble epoxide hydrolase inhibition by urea-like compounds. J Med Chem 46 (2003) 1066-1080
43. Pirrung M.C., Tumey L.N., McClerren A., and Raetz C.R.H. High-throughput catch-and-release synthesis of oxazoline hydroxamates. Structure-activity relationships in novel inhibitors of escherichia coli lpxc: in vitro enzyme inhibition and antibacterial properties. J Am Chem Soc 125 (2003) 1575-1586
44. Jain H.K., Mourya V.K., and Agrawal R.K. Inhibitory mode of 2-acetoxyphenyl alkyl sulfides against cox-1 and cox-2: QSAR analyses. Bioorg Med Chem Lett 16 (2006) 5280-5284
45. Hayatshahia SHS, Abdolmalekia P., Ghiasib M., and Safarian S. QSARs and activity predicting models for competitive inhibitors of adenosine deaminase. FEBS Lett 581 (2007) 506-514
46. Rameshwar U., Kadam R.U., Garg D., Chavan A., and Roy N. Evaluation of pseudomonas aeruginosa deacetylase lpxc inhibitory activity of dual pde4-tnfα inhibitors: A multiscreening approach. J Chem Inf Model 47 (2007) 1188-1195
47. Casanola-Martin G.M., Marrero-Ponce Y., Khan MTH, Ather A., Khan K.M., Torrens F., et al. Dragon method for finding novel tyrosinase inhibitors: biosilico identification and experimental in vitro assays. Eur J Med Chem 42 (2007) 1370-1381
48. Li J.Z., Du J., Xi L.L., Liu H.X., Yao X.J., and Liu M.C. Validated quantitative structure-activity relationship analysis of a series of 2-aminothiazole based p56(lck) inhibitors. Anal Chim Acta 631 (2009) 29-39
49. Goodarzi M., Freitas M.P., and Jensen R. Feature selection and linear/nonlinear regression methods for the accurate prediction of glycogen synthase kinase-3 beta inhibitory activities. J Chem Inf Model 49 (2009) 824-832
50. Helguera A.M., Duchowicz P.R., Cabrera M.A., Castro E.A., Cordeiro N., and González M.P. Application of the replacement method as a novel variable selection strategy in QSAR. 1. Carcinogenic potential. Chemometr Intell Lab Syst 81 (2006) 180-187
51. Helguera A.M., Cabrera M.A., and González M.P. Radial distribution function approach to predict rodent carcinogenicity. J Mol Model 19 (2006) 1-12
52. Toropov A.A., Rasulev B.F., and Leszczynski J. QSAR modeling of acute toxicity for nitrobenzene derivatives towards rats: comparative analysis by mlra and optimal descriptors. QSAR Comb Sci 26 (2007) 686-769
53. Helguera A.M., Cordeiro M., Cabrera M.A., Combes R.D., and González M.P. QSAR modelling of the rodent carcinogenicity of nitrocompounds. Bioorg Med Chem 15 (2008) 3395-3407
54. Helguera A.M., Cordeiro M., González M.P., and Cabrera M.A. Applications of 2d descriptors in drug design: a dragon tale. Curr Top Med Chem 8 (2008) 1628-1655
55. Helguera A.M., Rodríguez-Borges J., García-Mera X., Fernández F., and Cordeiro M. Probing the anticancer activity of nucleoside analogues: a QSAR model approach using an internally consistent training set. J Med Chem 50 (2007) 1537-1545
56. Cruz-Monteagudo M., Borges F., and Cordeiro M.N.D.S. Desirability-based multiobjective optimization for global QSAR studies: application to the design of novel nsaids with improved analgesic, antiinflammatory, and ulcerogenic profiles. J Comput Chem 29 (2008) 2445-2459
57. Cruz-Monteagudo M., Borges F., Cordeiro M.N.D.S., Fajin J.L.C., Morell C., Ruiz R.M., et al. Desirability-based methods of multiobjective optimization and ranking for global QSAR studies. Filtering safe and potent drug candidates from combinatorial libraries. J Comb Chemm 10 (2008) 897-913
58. Kazius J., McGuire R., and Bursi R. Derivation and validation of toxicophores for mutagenicity prediction. J Med Chem 48 (2005) 312-320
59. Acd/chemsketch 5.12 and acd/3d viewer are freeware from advanced chemistry development inc. isis(tm) draw 2.4 was obtained on internet from mdl information systems, Inc.
60. Frank J. MOPAC. Seiler Research Laboratory, US Air Force Academy, Colorado, Springs Co., 1993.
61. Duchowicz P.R., Castro E.A., and Fernndez F.M. Alternative algorithm for the search of an optimal set of descriptors in QSAR-QSPR studies. MATCH Commun Math Comput Chem 55 (2006) 179-192
62. Frank J. STATISTICA. Statsoft, Inc., 6.0 edition, 2002.
63. Kubinyi H. Variable selection in QSAR studies.1. an evolutionary algorithm. Quant Struct Act Relat 13 (1994) 285
64. Kubinyi H. Variable selection in QSAR studies. 2. A highly efficient combination of systematic search and evolution. Quant Struct Act Relat 13 (1994) 393
65. Cohen J. A coefficient of agreement for nominal scales. J Educat Psychol Measure 20 (1960) 37-46
66. Landis J.R., and Koch G.G. The measurement of observer agreement for categorical data. Biometrics 33 (1977) 159-174
67. Yasri A., and Hartsough D.J. Toward an optimal procedure for variable selection and QSAR model building. J Chem Inf Comput Sci 41 (2001) 1218-1227
68. Gore PAJ. Handbook of applied multivariate statistics and mathematical modeling. USA: Academic Press; 2000. p. 298-318.
69. McFarland JW, Gans D.J. Chemometric methods in molecular design. Weinheim: VCH; 1995. p. 295-307.
70. Johnson R.A., and Wichern D.W. Applied multivariate statistical analysis (1988), Prentice-Hall, New York
71. Eriksson L., Jaworska J., Worth A.P., Cronin MTD, McDowell R.M., and Gramatica P. Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-based QSARs. Environ Health Perspect 111 (2003) 1361-1375
72. Netzeva T.I., Worth A.P., Aldenberg T., Benigni R., Cronin MTD, Gramatica P., et al. Current status of methods for defining the applicability domain of (quantitative) structure-activity relationships. ATLA 33 (2005) 155-173
73. Gramatica P. Principles of QSAR models validation: internal and external. QSAR Comb Sci 00 (2007) 1-9
74. Vighi M., Gramatica P., Consolaro F., and Todeschini R. QSAR and chemometrics approaches for setting water quality objectives for dangerous chemicals. Ecotoxicol Environ Saf 49 (2001) 206-220
75. Benigni R., Alessandro G., Franke R., and Gruska A. Quantitative structure-activity relationships of mutagenic and carcinogenic aromatic amines. Chem Rev 100 (2000) 3697-3714
76. Eder E., and Weinfurtner E. Mutagenic and carcinogenic risk of oxygen containing chlorinated c-3 hydrocarbons: putative secondary products of c-3 chlorohydrocarbons and chlorination of water. Chemosphere 29 (1994) 2455-2466
77. Van Beerendonk G.J.M., Nivard M.J.M., Vogel E.W., Nelson S.D., and Meerman J.H.N. Formation of thymidine adducts and cross-linking potential of 2-bromoacrolein, a reactive metabolite of tris(2,3-dibromopropyl)phosphate. Mutagenesis 7 (1992) 19-24
78. Pérez-Garrido A., González M.P., and Escudero A.G. Halogenated derivatives QSAR model using spectral moments to predict haloacetic acids (haa) mutagenicity. Bioorg Med Chem 16 (2008) 5720-5732
79. Mekenyan O.G., Dimitrov S.D., Pavlov T.S., and Veith G.D. A systems approach to simulating metabolism in computational toxicology. I. The times heuristic modelling framework. Curr Pharm Des 10 (2004) 1273-1293
80. Benigni R. Chemical structure of mutagens and carcinogens and the relationship with biological activity. J Exp Clin Cancer Res 23 (2004) 5-8
81. Mekenyan O.G., Dimitrov S.D., Schmieder P., and Veith G.D. In silico modelling of hazard endpoints: current problems and perspectives. SAR QSAR Environ Res 14 (2003) 361-371
82. Ciaccio P.J., Gicquel E., O'Neill P.J., Scribner H.E., and Vandenberghe Y.L. Investigation of the positive response of ethyl acrylate in the mouse lymphoma genotoxicity assay. Toxicol Sci 46 (1998) 324-332
83. Feron V.J., Til H.P., de Vrijer F., Woutersen R.A., Cassee F.R., and van Bladeren P.J. Aldehydes: occurrence, carcinogenic potential, mechanism of action and risk assessment. Mutat Res 259 (1991) 363-385
84. Dearfield K.L., Harrington-Brock K., Doerr C.L., Rabinowitz J.R., and Moore M.M. Genotoxicity in mouse lymphoma cells of chemicals capable of michael addition. Mutagenesis 6 (1991) 519-525
85. Sanderson D.M., and Earnshaw C.G. Computer prediction of possible toxic action from chemical structure; the derek system. Human Exp Toxicol 10 (1991) 261-273
86. Enslein K., Gombar V.K., and Blake B.W. Use of sar in computer-assisted prediction of carcinogenicity and mutagenicity of chemicals by the topkat program. Mutat Res 305 (1994) 47-61
87. Benigni R., and Bossa C. structure alerts for carcinogenicity, and the Salmonella assay system: a novel insight through the chemical relational databases technology. Mutat Res 659 (2008) 248-261
88. Benigni R, Bossa C, Jeliazkova NG, Netzeva TI, Worth AP, editors. The Benigni/Bossa rulebase for mutagenicity and carcinogenicity-a module of Toxtree. Luxenbourg: EUR 23241 EN, EUR-Scientific and Technical Report Series, Office for the Official Publications of the European Communities, 2008.
89. Klopman G. Artificial intelligence approach to structure-activity studies. Computer automated structure evaluation of biological activity of organic molecules. J Am Chem Soc 106 (1984) 7315-7321
90. Klopman G., and Rosenkranz H.S. Structural requirements for the mutagenicity of environmental nitroarenes. Mutation Res 126 (1984) 227-238
91. Klopman G. Multicase 1. A hierarchical computer automated structure evaluation program. Quant Struct Activity Relationships 11 (1992) 176-184
92. Klopman G., and Rosenkranz H.S. Prediction of carcinogenicity/mutagenicity using multicase. Mutat Res 305 (1994) 33-46
93. Tunkel T., Mayo K., Austin C., Hickerson A., and Howard P. Practical considerations on the use of predictive models for regulatory purposes. Environ Sci Technol 39 (2005) 2188-2199